# Study on Prevalence and Impact of Brain Metastases on Survival in Lung Cancer by Line of Treatment

> **NCT06557967** · — · COMPLETED · sponsor: **Daiichi Sankyo** · enrollment: 22517 (actual)

## Conditions studied

- Non-small Cell Lung Cancer
- Lung Cancer
- Metastatic Cancer
- Brain and Central Nervous System Cancer

## Interventions

- **OTHER:** No drug

## Key facts

- **NCT ID:** NCT06557967
- **Lead sponsor:** Daiichi Sankyo
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2024-03-01
- **Primary completion:** 2024-06-28
- **Final completion:** 2024-09-30
- **Target enrollment:** 22517 (ACTUAL)
- **Last updated:** 2024-12-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06557967

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06557967, "Study on Prevalence and Impact of Brain Metastases on Survival in Lung Cancer by Line of Treatment". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT06557967. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
